For researchers and students at the University of Oslo, researchers at Oslo University Hospital (OUS) and Akershus University Hospital (Ahus), members of Norway Health Tech, The Life Science Cluster, LMI, Oslo Cancer Cluster, Aleap, the Oslo Science Park community and Oslo Science City partners. Free of charge, but you have to sign up.
Programme
Inspirational talk
Elen H?eg, head of the open innovation arena Health2B
More about the speaker, her talk and Health2B
Elen is an experienced life science enthusiast with a degree in pharmacy from UiO 2000. She has a broad background from pharmaceutical industry, working across the pharmaceutical development value chain from regulatory, clinical, GMP/manufacturing to health technology assessment and procurement.
She has worked in various organisations from start up biotech to industry organisation to big pharma to global health partnerships. Before joining Health2B in October 2023, Elen through her 4 years in Coalition for Pandemic Preparedness Innovations (CEPI) carried a key role in the COVID-19 pandemic response through CEPIs work on policy and partnerships. Elen has a solid track-record in fostering partnerships in the interphase of science and policy both on national and global level, informing and driving key ecosystem and framework changes to enable innovation and access. She thrives from fostering relationships and connecting dots within and across organisations.
Founded in 2022 by the Oslo University Hospital, Norway Health Tech and Oslo Science Park, Health2B is a brand new concept for collaboration based on open innovation. Health2B serves as a door opener between business and the public health service and aims to realize the health service of the future through strengthened public-private, public-public and private-private collaboration.
In her talk she will share her experience and her reflections on the needs for health innovation and collaboration and the role of Health2B in this regards.
Role model talk
Gard Fostad Moe, CEO, Aristeia AS
More about the speaker, his talk and Aristeia AS
Gard is according to himself "a hillbilly biophysicist from ?s, dubbed the Tuscany of the Nordics". He holds a master’s degree in applied physics and mathematics from NTNU, where he poked small gas bubbles to see how bouncy they were and conversed with them using ultrasound.
During his time at NTNU Gard founded Vektorprogrammet, a STEM-promoting organization that recently celebrated 10 years. He went to work on a new tourniquet, a bleeding control device, immediately after his stint at university, a concept he invented while cooking.
Aristeia AS the stock company was founded in December 2015 and immediately entered into a collaboration with the Norwegian Defence Research Establishment and the Norwegian Armed Forces. The company also received backing from the Norwegian Ministry of Defence. Currently the company is operating under a testing regime with the US Department of Defence and its Naval Medical Research Unit – San Antonio, while also maintaining close relations with trauma care researchers in Europe and the US.
In his talk he will share his experience as an entrepreneur, both upsides and downsides.
Meet the companies
Pitches from companies.
Norwegian Industrial Property Office (NIPO)
FornixVR
